⌘K

Login Start Free

Home/Filings/4/0000950170-24-070564

4//SEC Filing

Suri Anish 4

Accession 0000950170-24-070564

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 4:00 PM ET

Size

5.3 KB

Accession

0000950170-24-070564

Insider Transaction Report

Form 4

Period: 2024-06-05

Cue Biopharma, Inc.CUE

Chief Scientific Officer

Transactions

Award
Stock Option (right to buy)
2024-06-05+150,000→ 150,000 total
Exercise: $1.65Exp: 2034-06-04→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on December 5, 2024.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0001739130

Filing Metadata

Form type: 4
Filed: Jun 6, 8:00 PM ET
Accepted: Jun 7, 4:00 PM ET
Size: 5.3 KB

View on SEC.gov